UPDATE: Wedbush Starts Y-mAbs Therapeutics Inc. (YMAB) at Outperform

September 3, 2019 4:12 PM EDT
Get Alerts YMAB Hot Sheet
Price: $32.73 -7.36%

Rating Summary:
    10 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 25 | Down: 37 | New: 115
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - September 3, 2019 4:16 PM EDT)

(updated to correct ticker)

Wedbush analyst David Nierengarten initiates coverage on Y-mAbs Therapeutics (NASDAQ: YMAB)) with a Outperform rating and a price target of $38.00.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot New Coverage, New Coverage